The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials
Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americ...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Li, Xia [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A new global analytical potential energy surface of NaH - Yuan, Meiling ELSEVIER, 2018, official journal of the World Federation of Neurology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:332 ; year:2013 ; number:1 ; day:15 ; month:09 ; pages:92-96 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jns.2013.06.025 |
|---|
| Katalog-ID: |
ELV011931000 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV011931000 | ||
| 003 | DE-627 | ||
| 005 | 20230623093455.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jns.2013.06.025 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013021000015.pica |
| 035 | |a (DE-627)ELV011931000 | ||
| 035 | |a (ELSEVIER)S0022-510X(13)00302-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.10 |2 bkl | ||
| 100 | 1 | |a Li, Xia |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| 264 | 1 | |c 2013 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. | ||
| 700 | 1 | |a Zhou, Guoyu |4 oth | |
| 700 | 1 | |a Zhou, Xueying |4 oth | |
| 700 | 1 | |a Zhou, Shengnian |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Yuan, Meiling ELSEVIER |t A new global analytical potential energy surface of NaH |d 2018 |d official journal of the World Federation of Neurology |g Amsterdam [u.a.] |w (DE-627)ELV001315870 |
| 773 | 1 | 8 | |g volume:332 |g year:2013 |g number:1 |g day:15 |g month:09 |g pages:92-96 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jns.2013.06.025 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.10 |j Physikalische Chemie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 332 |j 2013 |e 1 |b 15 |c 0915 |h 92-96 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
x l xl |
|---|---|
| matchkey_str |
lixiazhouguoyuzhouxueyingzhoushengnian:2013----:hefccadaeyfsiipudprdmlvruaprnneodrpeetofloigiosrkaea |
| hierarchy_sort_str |
2013 |
| bklnumber |
35.10 |
| publishDate |
2013 |
| allfields |
10.1016/j.jns.2013.06.025 doi GBVA2013021000015.pica (DE-627)ELV011931000 (ELSEVIER)S0022-510X(13)00302-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Li, Xia verfasserin aut The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. Zhou, Guoyu oth Zhou, Xueying oth Zhou, Shengnian oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 https://doi.org/10.1016/j.jns.2013.06.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 332 2013 1 15 0915 92-96 5 045F 610 |
| spelling |
10.1016/j.jns.2013.06.025 doi GBVA2013021000015.pica (DE-627)ELV011931000 (ELSEVIER)S0022-510X(13)00302-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Li, Xia verfasserin aut The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. Zhou, Guoyu oth Zhou, Xueying oth Zhou, Shengnian oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 https://doi.org/10.1016/j.jns.2013.06.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 332 2013 1 15 0915 92-96 5 045F 610 |
| allfields_unstemmed |
10.1016/j.jns.2013.06.025 doi GBVA2013021000015.pica (DE-627)ELV011931000 (ELSEVIER)S0022-510X(13)00302-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Li, Xia verfasserin aut The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. Zhou, Guoyu oth Zhou, Xueying oth Zhou, Shengnian oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 https://doi.org/10.1016/j.jns.2013.06.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 332 2013 1 15 0915 92-96 5 045F 610 |
| allfieldsGer |
10.1016/j.jns.2013.06.025 doi GBVA2013021000015.pica (DE-627)ELV011931000 (ELSEVIER)S0022-510X(13)00302-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Li, Xia verfasserin aut The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. Zhou, Guoyu oth Zhou, Xueying oth Zhou, Shengnian oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 https://doi.org/10.1016/j.jns.2013.06.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 332 2013 1 15 0915 92-96 5 045F 610 |
| allfieldsSound |
10.1016/j.jns.2013.06.025 doi GBVA2013021000015.pica (DE-627)ELV011931000 (ELSEVIER)S0022-510X(13)00302-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 VZ 35.10 bkl Li, Xia verfasserin aut The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. Zhou, Guoyu oth Zhou, Xueying oth Zhou, Shengnian oth Enthalten in Elsevier Science Yuan, Meiling ELSEVIER A new global analytical potential energy surface of NaH 2018 official journal of the World Federation of Neurology Amsterdam [u.a.] (DE-627)ELV001315870 volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 https://doi.org/10.1016/j.jns.2013.06.025 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.10 Physikalische Chemie: Allgemeines VZ AR 332 2013 1 15 0915 92-96 5 045F 610 |
| language |
English |
| source |
Enthalten in A new global analytical potential energy surface of NaH Amsterdam [u.a.] volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 |
| sourceStr |
Enthalten in A new global analytical potential energy surface of NaH Amsterdam [u.a.] volume:332 year:2013 number:1 day:15 month:09 pages:92-96 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Physikalische Chemie: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
A new global analytical potential energy surface of NaH |
| authorswithroles_txt_mv |
Li, Xia @@aut@@ Zhou, Guoyu @@oth@@ Zhou, Xueying @@oth@@ Zhou, Shengnian @@oth@@ |
| publishDateDaySort_date |
2013-01-15T00:00:00Z |
| hierarchy_top_id |
ELV001315870 |
| dewey-sort |
3610 |
| id |
ELV011931000 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011931000</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623093455.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jns.2013.06.025</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013021000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011931000</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-510X(13)00302-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.10</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Xia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Guoyu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Xueying</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Shengnian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Yuan, Meiling ELSEVIER</subfield><subfield code="t">A new global analytical potential energy surface of NaH</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the World Federation of Neurology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001315870</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:332</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:92-96</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jns.2013.06.025</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.10</subfield><subfield code="j">Physikalische Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">332</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">0915</subfield><subfield code="h">92-96</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Li, Xia |
| spellingShingle |
Li, Xia ddc 610 ddc 540 bkl 35.10 The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| authorStr |
Li, Xia |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001315870 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 VZ 35.10 bkl The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| topic |
ddc 610 ddc 540 bkl 35.10 |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.10 |
| topic_browse |
ddc 610 ddc 540 bkl 35.10 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
g z gz x z xz s z sz |
| hierarchy_parent_title |
A new global analytical potential energy surface of NaH |
| hierarchy_parent_id |
ELV001315870 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
A new global analytical potential energy surface of NaH |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001315870 |
| title |
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| ctrlnum |
(DE-627)ELV011931000 (ELSEVIER)S0022-510X(13)00302-X |
| title_full |
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| author_sort |
Li, Xia |
| journal |
A new global analytical potential energy surface of NaH |
| journalStr |
A new global analytical potential energy surface of NaH |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
92 |
| author_browse |
Li, Xia |
| container_volume |
332 |
| physical |
5 |
| class |
610 610 DE-600 540 VZ 35.10 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Li, Xia |
| doi_str_mv |
10.1016/j.jns.2013.06.025 |
| dewey-full |
610 540 |
| title_sort |
efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following tia or stroke: a meta-analysis of randomized controlled trials |
| title_auth |
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| abstract |
Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. |
| abstractGer |
Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. |
| abstract_unstemmed |
Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials |
| url |
https://doi.org/10.1016/j.jns.2013.06.025 |
| remote_bool |
true |
| author2 |
Zhou, Guoyu Zhou, Xueying Zhou, Shengnian |
| author2Str |
Zhou, Guoyu Zhou, Xueying Zhou, Shengnian |
| ppnlink |
ELV001315870 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.jns.2013.06.025 |
| up_date |
2024-07-06T21:06:32.694Z |
| _version_ |
1803865285140152320 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV011931000</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623093455.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jns.2013.06.025</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013021000015.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV011931000</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0022-510X(13)00302-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.10</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Xia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: A meta-analysis of randomized controlled trials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Stroke is becoming a common disease worldwide, and has an increased rate of recurrence yearly after a transient ischemic attack (TIA) or stroke. Aspirin, dipyridamole, clopidogrel and aspirin plus dipyridamole combination therapy have been recommended for the secondary prevention of stroke in Americans.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Guoyu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Xueying</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhou, Shengnian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Yuan, Meiling ELSEVIER</subfield><subfield code="t">A new global analytical potential energy surface of NaH</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the World Federation of Neurology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001315870</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:332</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:15</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:92-96</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jns.2013.06.025</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.10</subfield><subfield code="j">Physikalische Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">332</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">15</subfield><subfield code="c">0915</subfield><subfield code="h">92-96</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4000416 |